Tyson named chair of Executive Leadership Council

Tuesday, January 31, 2012 07:51 AM

Bernard Tyson, president and COO of Kaiser Permanente, has been named chair of the Executive Leadership Council (ELC)—a preeminent organization composed of African-American senior executives from the nation's Fortune 500 corporations that recognizes the strengths, success, contributions and impact of African-American business leaders. His term runs through Dec. 31, 2013.

"As chair, my role is to harness the collective energy and intellect of the ELC for the benefit of corporate America," Tyson said. "We must continue our focus on increasing the presence of highly qualified, capable and competent African-Americans at the CEO level or one to two levels below and on the boards of publicly-traded companies."

Tyson has been recognized for his work both within and outside of health care. In 2010 he was named one of the 25 most influential African Americans in health care by Black Health magazine, and one of the top 25 minority executives in the nation by Modern Healthcare. He currently serves on the board of the American Heart Association and Occidental College in Los Angeles, and is engaged in many philanthropic and community-based events.

"Bernard is an extremely effective leader with a demonstrated track record of achievement through collaboration, inclusion and acceptance," said George C. Halvorson, chairman and CEO of Kaiser Permanente. "His methods have produced very powerful outcomes within Kaiser Permanente. I am certain he will bring the same spirit to the ELC."

Arnold W. Donald, president and CEO of the ELC, said, "Bernard has been a very active member [of ELC] for many years, and we look forward to benefiting from his knowledge, creativity and guidance as we advance our efforts to increase African-American leadership at the most senior levels and on the boards of America's largest corporations.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs